New York tops US technology-transfer league

    A survey has ranked high earners from technology-licensing income among US universities, hospitals, research institutions and investment firms during fiscal year 2007.

    Of the 185 respondents that allowed their data to be published, New York University earned the most at $791 million, much of it from selling partial royalty rights to the autoimmune-disease drug Remicade. Massachusetts General Hospital in Boston was second with $346 million. Columbia University in New York, which has licensed drug therapies, medical devices and consumer electronics technologies, took in $136 million.

    Research at the institutions surveyed resulted in the creation of 555 start-up companies, led by the University of California System with 38. The survey, released on 26 January, was conducted by the non-profit Association of University Technology Managers.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    New York tops US technology-transfer league. Nature 457, 648 (2009). https://doi.org/10.1038/457648e

    Download citation

    Comments

    By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.